BeiGene

BeiGene, which plans to change its name to BeOne Medicines Ltd., is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them.

Date, time and room information

May 5, 16:15 - 16:30, room Osaka/Samarkand

Category
Commercial stage company
Title of the presentation
BeiGene: Building a new model for global oncology innovation
Speaker information
Name Position Institution
Giancarlo Benelli Senior Vice President and Head of Europe BeiGene